Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)

Electrospun nonwovens loaded with the anti‐Malaria drug Artemisone could be utilized as most efficient carrier without direct patient contact by infusion systems. The electrospun nonwovens allow high loading of Artemisone and excellent mass transfer. Drug release rate and dose could be controlled by...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagheri, Amir Reza, Agarwal, Seema, Golenser, Jacob, Greiner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607210/
http://dx.doi.org/10.1002/gch2.201770006
_version_ 1783432048947494912
author Bagheri, Amir Reza
Agarwal, Seema
Golenser, Jacob
Greiner, Andreas
author_facet Bagheri, Amir Reza
Agarwal, Seema
Golenser, Jacob
Greiner, Andreas
author_sort Bagheri, Amir Reza
collection PubMed
description Electrospun nonwovens loaded with the anti‐Malaria drug Artemisone could be utilized as most efficient carrier without direct patient contact by infusion systems. The electrospun nonwovens allow high loading of Artemisone and excellent mass transfer. Drug release rate and dose could be controlled by choice of infusion media and infusion rate. Details can be found in the article number 1600011 by Amir Reza Bagheri, Seema Agarwal, Jacob Golenser, and Andreas Greiner*. [Image: see text]
format Online
Article
Text
id pubmed-6607210
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66072102019-09-27 Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017) Bagheri, Amir Reza Agarwal, Seema Golenser, Jacob Greiner, Andreas Glob Chall Back Cover Electrospun nonwovens loaded with the anti‐Malaria drug Artemisone could be utilized as most efficient carrier without direct patient contact by infusion systems. The electrospun nonwovens allow high loading of Artemisone and excellent mass transfer. Drug release rate and dose could be controlled by choice of infusion media and infusion rate. Details can be found in the article number 1600011 by Amir Reza Bagheri, Seema Agarwal, Jacob Golenser, and Andreas Greiner*. [Image: see text] John Wiley and Sons Inc. 2017-02-24 /pmc/articles/PMC6607210/ http://dx.doi.org/10.1002/gch2.201770006 Text en © 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Back Cover
Bagheri, Amir Reza
Agarwal, Seema
Golenser, Jacob
Greiner, Andreas
Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title_full Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title_fullStr Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title_full_unstemmed Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title_short Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
title_sort global health: unlocking nanocarriers for the programmed release of antimalarial drugs (global challenges 2/2017)
topic Back Cover
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607210/
http://dx.doi.org/10.1002/gch2.201770006
work_keys_str_mv AT bagheriamirreza globalhealthunlockingnanocarriersfortheprogrammedreleaseofantimalarialdrugsglobalchallenges22017
AT agarwalseema globalhealthunlockingnanocarriersfortheprogrammedreleaseofantimalarialdrugsglobalchallenges22017
AT golenserjacob globalhealthunlockingnanocarriersfortheprogrammedreleaseofantimalarialdrugsglobalchallenges22017
AT greinerandreas globalhealthunlockingnanocarriersfortheprogrammedreleaseofantimalarialdrugsglobalchallenges22017

Ejemplares similares